Identification of Ras farnesyltransferase inhibitors by microbial screening.
about
Rational design of small molecule inhibitors targeting the Ras GEF, SOS1.Structures of Cryptococcus neoformans Protein Farnesyltransferase Reveal Strategies for Developing Inhibitors That Target Fungal PathogensA KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotypeThematic review series: lipid posttranslational modifications. Fighting parasitic disease by blocking protein farnesylationProtein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude miceContribution of Src and Ras pathways in FGF-2 induced endothelial cell differentiation.Targeting protein prenylation for cancer therapyA genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications.Upregulation of nuclear factor-kappaB expression by SLURP-1 is mediated by alpha7-nicotinic acetylcholine receptor and involves both ionic events and activation of protein kinases.Ras farnesyltransferase inhibitors suppress the phenotype resulting from an activated ras mutation in Caenorhabditis elegans.Lipid posttranslational modifications. Farnesyl transferase inhibitors.Multimutated herpes simplex virus g207 is a potent inhibitor of angiogenesis.Consequences of altered isoprenylation targets on a-factor export and bioactivity.P2Y(2) receptor-mediated proliferation of C(6) glioma cells via activation of Ras/Raf/MEK/MAPK pathway.Biosynthesis of colabomycin E, a new manumycin-family metabolite, involves an unusual chain-length factor.The prenylation inhibitor manumycin A reduces the viability of Anaplasma phagocytophilumCombined rational design and a high throughput screening platform for identifying chemical inhibitors of a Ras-activating enzymeA dual-targeting approach to inhibit Brucella abortus replication in human cells.Manumycin A inhibits triple-negative breast cancer growth through LC3-mediated cytoplasmic vacuolation death.Inhibition of protein farnesylation enhances the chemotherapeutic efficacy of the novel geranylgeranyltransferase inhibitor BAL9611 in human colon cancer cells.Fungal lipopeptide mating pheromones: a model system for the study of protein prenylationInhibition of farnesyltransferase: a rational approach to treat cancer?Fibroblast growth factor-2 promotes catabolism via FGFR1-Ras-Raf-MEK1/2-ERK1/2 axis that coordinates with the PKCδ pathway in human articular chondrocytes.Manumycin A corrects aberrant splicing of Clcn1 in myotonic dystrophy type 1 (DM1) mice.Inhibitors of cellular signalling are cytotoxic or block the budded-to-hyphal transition in the pathogenic yeast Candida albicans.Coupling of ionic events to protein kinase signaling cascades upon activation of alpha7 nicotinic receptor: cooperative regulation of alpha2-integrin expression and Rho kinase activity.Antitumor compounds from marine actinomycetes.Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases.Allylic structures in cancer drugs and body metabolites that control cell life and death.Manumycin inhibits ras signal transduction pathway and induces apoptosis in COLO320-DM human colon tumour cells.Modulation of RhoA-Rho kinase-mediated Ca2+ sensitization of rabbit myometrium during pregnancy - role of Rnd3.Cell growth inhibition by farnesyltransferase inhibitors is mediated by gain of geranylgeranylated RhoB.Enhanced antiproliferative and apoptotic response of HT-29 adenocarcinoma cells to combination of photoactivated hypericin and farnesyltransferase inhibitor manumycin AManumycin inhibits farnesyltransferase and induces apoptosis of drug-resistant interleukin 6-producing myeloma cells.Apoptosis of medulloblastoma cells in vitro follows inhibition of farnesylation using manumycin A.Suppression of human pancreatic cancer growth in BALB/c nude mice by manumycin, a farnesyl:protein transferase inhibitor.Farnesyltransferase as a target for anticancer drug design.Inhibitors of the Ras signal transduction pathway as potential antitumour agents.A mutant form of human protein farnesyltransferase exhibits increased resistance to farnesyltransferase inhibitors.Manumycin and gliotoxin derivative KT7595 block Ras farnesylation and cell growth but do not disturb lamin farnesylation and localization in human tumour cells.
P2860
Q27318713-7345E098-79FB-4598-BF5E-DB616AB85D8AQ27671538-FBA7C507-50F6-4235-B443-BEA26BE331E9Q28117127-1D59A3F3-2B4D-410A-B3DB-AAE6456CBD4AQ28285888-6D47D802-19CB-4D9A-992A-DCD70814702CQ28369454-FA14EFF0-5487-4100-B356-AE07B4A39F6FQ30711403-FFA6BB7C-B88F-42E3-953F-F56C8B85775BQ33679239-42FED719-8788-482E-92AC-53407292C97CQ33900952-9243C01A-1700-455A-A5BD-2200D779A461Q34304838-437AB1A0-3B36-4408-8759-EE687E29A52AQ34434642-1ED62368-BF56-47BA-8656-444D6A969CB6Q34651253-CE5A3191-4B8A-47E9-8A04-D4A844D8BEDBQ34928710-ED3FC896-39AB-435B-9D2E-8727DDFF4D36Q35038534-2BF24329-441D-426F-944C-F8E76B55FD7CQ35042080-7E08DC68-35B7-430D-8F6F-415B6E0FEAB3Q35170571-7A2470EB-FA40-40D0-B360-3F7EAD07399FQ35199212-E991EEF8-4AFE-4C15-AEA3-2543117499FCQ35590750-C00D91DD-5DDD-4875-93F6-AE6D77FD2D96Q36170389-0B96FE11-31F5-4A6D-9B6A-9070ED3A55C2Q36586495-596F76E4-C2BD-4157-BBD4-53B1D87676EAQ36622317-378605EA-4113-4601-AE86-AAA127F8C6C2Q36669959-EA2DFE80-1272-478D-B9E8-1EA4D6C76716Q36828655-F70AFF41-C21F-4CDE-A2D6-8BABFDCEC78CQ36934976-CEE7C339-4395-4E80-9929-52B496AFE7E1Q36983716-5C72FAEE-E480-42AB-97E4-09F7E7212179Q37343625-02084A36-A823-40E7-8506-A39B49F5E74FQ37372238-09D8685D-48BE-45C8-BE92-9058F7BFB17EQ37549963-AB8D0AEF-111D-4DE1-B0BE-C6F48C7B5967Q37880161-7F4FF6B8-1212-4021-BE1F-C1018FF997F6Q38089154-83CE629D-24DB-4D8E-804E-D03F6DEE1025Q38274079-6AC63318-FF11-4078-B5BC-88B525521165Q38349188-E6A8C1BF-CCE3-4A22-90BB-1084906B19EFQ39444763-10F9E1A8-57E5-4972-816D-0EB26CDAA1FCQ40360176-31F6629F-CA00-485D-A3BA-F492751F8BA5Q40720447-5BC6A569-6FC1-42C1-959F-150841FA91FAQ40942828-43E1DEEE-614B-4A48-B438-D476C3377A40Q41234843-E2D0E9DE-26C8-45D2-8DD7-ACA98D784310Q41489707-757D76CD-5744-404B-B718-3D5E27BCD82FQ41515936-FECC6062-5448-4D79-B8CC-8106D68FA5DFQ41689650-EDE34A8B-295A-46AE-98B7-C053A2A1146CQ41931496-6E7F66D2-5989-46DA-B809-E358949AB15F
P2860
Identification of Ras farnesyltransferase inhibitors by microbial screening.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Identification of Ras farnesyltransferase inhibitors by microbial screening.
@ast
Identification of Ras farnesyltransferase inhibitors by microbial screening.
@en
type
label
Identification of Ras farnesyltransferase inhibitors by microbial screening.
@ast
Identification of Ras farnesyltransferase inhibitors by microbial screening.
@en
prefLabel
Identification of Ras farnesyltransferase inhibitors by microbial screening.
@ast
Identification of Ras farnesyltransferase inhibitors by microbial screening.
@en
P2093
P2860
P356
P1476
Identification of Ras farnesyltransferase inhibitors by microbial screening.
@en
P2093
P2860
P304
P356
10.1073/PNAS.90.6.2281
P407
P577
1993-03-01T00:00:00Z